Literature DB >> 31853040

Role of complement 3 in the pathogenesis of hypertension.

Lan Chen1, Noboru Fukuda2,3, Taro Matsumoto4, Masanori Abe5.   

Abstract

The complement system has recently been reported to contribute to the development and pathogenesis of hypertension, several cardiovascular and renal diseases, and cardiometabolic disorders accompanied by inflammation and tissue remodeling. We have demonstrated that complement 3 (C3) is highly expressed in mesenchymal tissues in spontaneously hypertensive rats (SHRs) and induces the synthetic phenotype and exaggerated growth of mesenchymal cells by maintenance effect on dedifferentiated cells. To verify the role of C3 in the pathogenesis of hypertension, we targeted the C3 gene from SHRs by zinc-finger nuclease gene-editing technology and demonstrated that the increased expression of C3 induces salt-sensitive hypertension with activation of the renal renin-angiotensin system in SHRs. We recently found that increased expression of C3 is associated with the suppression of miR145 and induces Krüppel-like factor 5 and the synthetic phenotype of mesenchymal cells in SHRs. We also demonstrated that C3 is involved in the epithelial-to-mesenchymal transition and dedifferentiation of epithelial cells in kidneys subjected to unilateral ureteral obstruction with elevation of blood pressure. Thus, C3 is an essential factor in the pathogenesis of hypertension due to its maintenance effect on undifferentiated mesenchymal cells.

Entities:  

Keywords:  Complement 3; Epithelial-to-mesenchymal transition; Hypertension Mesenchymal cell; Spontaneously hypertensive rat

Mesh:

Substances:

Year:  2019        PMID: 31853040     DOI: 10.1038/s41440-019-0371-y

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  78 in total

1.  Human complement component C3: cDNA coding sequence and derived primary structure.

Authors:  M H de Bruijn; G H Fey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

2.  Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation.

Authors:  M Lévi-Strauss; M Mallat
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

Review 3.  Resistant hypertension--its identification and epidemiology.

Authors:  Pantelis A Sarafidis; Panagiotis Georgianos; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

4.  Complement component C3 functions as an embryotrophic factor in early postimplantation rat embryos.

Authors:  Makoto Usami; Katsuyoshi Mitsunaga; Atsuko Miyajima; Momoko Sunouchi; Osamu Doi
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

5.  Complement c3a and c5a induce different signal transduction cascades in endothelial cells.

Authors:  Ingrid U Schraufstatter; Khanh Trieu; Lyudmila Sikora; P Sriramarao; Richard DiScipio
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

Review 6.  Oxidative stress and hypertension.

Authors:  David G Harrison; Maria Carolina Gongora
Journal:  Med Clin North Am       Date:  2009-05       Impact factor: 5.456

7.  C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.

Authors:  Ingrid U Schraufstatter; Richard G Discipio; Ming Zhao; Sophia K Khaldoyanidi
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

8.  Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I.

Authors:  J Legoedec; P Gasque; J F Jeanne; M Fontaine
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

Review 9.  Hypertension: physiology and pathophysiology.

Authors:  John E Hall; Joey P Granger; Jussara M do Carmo; Alexandre A da Silva; John Dubinion; Eric George; Shereen Hamza; Joshua Speed; Michael E Hall
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

10.  The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo.

Authors:  W A Schumacher; J C Fantone; S E Kunkel; R C Webb; B R Lucchesi
Journal:  Agents Actions       Date:  1991-11
View more
  1 in total

1.  Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy.

Authors:  Yunzhu Shen; Tangli Xiao; ZhiKai Yu; Yinghui Huang; Ting He; Haiyang Li; Jun Zhang; Jiachuan Xiong; Jinghong Zhao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.